234 related articles for article (PubMed ID: 17319493)
1. [Novel tumor marker discovery of gastrointestinal cancers using various proteomic approaches].
Tomonaga T; Nomura F
Rinsho Byori; 2007 Jan; 55(1):63-8. PubMed ID: 17319493
[TBL] [Abstract][Full Text] [Related]
2. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
3. Proteomics of breast carcinoma.
Somiari RI; Somiari S; Russell S; Shriver CD
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
[TBL] [Abstract][Full Text] [Related]
4. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
Hirano T; Kato H
Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
[TBL] [Abstract][Full Text] [Related]
5. Cancer proteomics: Serum diagnostics for tumor marker discovery.
Rai AJ; Chan DW
Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
[TBL] [Abstract][Full Text] [Related]
6. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
7. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics and mass spectrometry profiling for cancer detection.
Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
10. Artificial neural networks and decision tree model analysis of liver cancer proteomes.
Luk JM; Lam BY; Lee NP; Ho DW; Sham PC; Chen L; Peng J; Leng X; Day PJ; Fan ST
Biochem Biophys Res Commun; 2007 Sep; 361(1):68-73. PubMed ID: 17644064
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
12. Proteomic approaches in lung cancer biomarker development.
Cho JY; Sung HJ
Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
[TBL] [Abstract][Full Text] [Related]
13. Proteomics and the haematologist.
Rees-Unwin KS; Morgan GJ; Davies FE
Clin Lab Haematol; 2004 Apr; 26(2):77-86. PubMed ID: 15053800
[TBL] [Abstract][Full Text] [Related]
14. The molecular make-up of a tumour: proteomics in cancer research.
Kolch W; Mischak H; Pitt AR
Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
[TBL] [Abstract][Full Text] [Related]
15. Proteomics: recent applications and new technologies.
Elrick MM; Walgren JL; Mitchell MD; Thompson DC
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
[TBL] [Abstract][Full Text] [Related]
16. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
17. [Application of proteomic approach for solid tumor marker discovery].
Ni XG; Zhao P; Liu Y; Zhao XH
Ai Zheng; 2003 Jun; 22(6):664-7. PubMed ID: 12948422
[TBL] [Abstract][Full Text] [Related]
18. Proteomic technologies and their application to pancreatic cancer.
Vimalachandran D; Costello E
Expert Rev Proteomics; 2004 Dec; 1(4):493-501. PubMed ID: 15966844
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
20. [The therapeutic contribution of proteomic approaches in cancers].
Hamrita B; Nasr HB; Kabbage M; Hamann P; Kuhn L; Guillier C; Remadi S; Chaieb A; Khairi H; Chouchane L; Chahed K
Gynecol Obstet Fertil; 2011 Feb; 39(2):87-93. PubMed ID: 21317010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
